In the inaugural episode, AON's Fred Divers, MD, explains why the network exited CMS's Enhancing Oncology Model over opaque benchmarks, data delays and shifting rules.
Business of Value
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
2
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
3
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
4
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
5